UPDATE : Tuesday, August 11, 2020
Celltrion Healthcare presents Remsima SC in UK by Lee Han-soo 2020-03-02 17:42
HLB seeks new pipelines by taking over US biotech firm by Jeong Sae-im 2020-02-21 15:42
Celltrion’s annual revenue surpassed ₩1 trillion in 2019 by Jeong Sae-im 2020-02-20 15:47
Prescription of Celltrion’s Remsima SC started in Germany by Jeong Sae-im 2020-02-18 16:05
Korea University analyzes 5,000 cancer patients’ genomic data  by Kim Yun-mi 2020-02-11 15:49
Sillajen's loss more than doubles due to Pexa-Vec trial failure by Jeong Sae-im 2020-02-03 16:08
Kolon CEO arrested for mislabeling Invossa’s ingredient by Jeong Sae-im 2020-02-03 15:34
Interpark embarks on organoid business by Park Gi-taek 2020-01-27 11:18
Samsung BioLogics’ annual sales up 30% on contract research growth by Jeong Sae-im 2020-01-23 14:47
Celltrion Group to build biopharmaceutical plant in China by Lee Han-soo 2020-01-21 18:00
Korea’s biopharma power shines at JP Morgan Healthcare meet by Jeong Sae-im 2020-01-17 15:20
HLB stocks fall in after-hours trading due to interview on rivoceranib by Jeong Sae-im 2020-01-16 15:46
Mundipharma to commercialize Samsung Bioepis’ biosimilar in Hong Kong, Taiwan by Lee Han-soo 2020-01-13 16:23
BioMarin seeks license for gene therapy to treat hemophilia by Kim Yun-mi 2020-01-06 16:44
[New Year Special] Biotech rookies may shake up market cap rankings by Jeong Sae-im 2020-01-02 14:31
Humedix wins patent on new anti-aging material by Jeong Sae-im 2019-12-26 14:31
Vaxcell-Bio Therapeutics passes tech review for Kosdaq debut by Jeong Sae-im 2019-12-23 15:42
Samsung Bioepis’ Ontruzant 1st biosimilar to win WHO's PQ certification by Lee Han-soo 2019-12-20 16:29
Kolon appeals Invossa’s safety in pleading at court by Jeong Sae-im 2019-12-20 14:57
4 firms to offer up to 56 direct-to-consumer genetic testing services by Jeong Sae-im 2019-12-19 16:40
Back to Top